再生醫學/細胞治療
NEW

醫事司劉越萍：再生醫療法明年增修子法規 強化人員訓練、廣告、倫理  
生技醫藥
NEW

擊敗嬌生？GSK三期多發性骨髓瘤ADC捲土重來

新聞集錦
NEW

MSD斥5.88億美元 取中國禮新PD-1/VEGF雙靶點抗體藥；Gilead關閉西雅圖辦事處 明年年中再關Kite費城工廠

GBI International
GBIHighlights

BUDDHIST TZU CHI GENERAL HOSPITAL teams up with Google Cloud to revolutionize healthcare

2023-12-31/GlobalBio & Investment
FromCharityto #Medtech. BUDDHISTTZUCHIGENERALHOSPITAL teamsupwith GoogleCloud torevolutionize #healthcare!Atthe2023 Healthcare+ExpoTaiwan,theyannouncedapartnershipwith EBMTechnologies tocreateasecure ...
GBI International
GBIHighlights

Sunny Pharmtech Inc.’s CPA-I successfully dispatched its inaugural shipment on 30th November

2023-12-31/GlobalBio & Investment
SunnyPharmtechInc.祥翊製藥股份有限公司’sgenericdruginjectable,Cyclophosphamide(CPA-I),successfullydispatcheditsinauguralshipmenton30thNovember,targetinga$100millionmarket.ThisFDA-approvedCPA-I,grantedinla...
GBI International
GBIHighlights

Dr. Hsing-Pang Hsieh, Director of IBPR at NHRI is elected to the National Academy of Inventors

2023-12-31/GlobalBio & Investment
Goldalwaysglitters!CongratulationstoDr. Hsing-PangHsieh,Directorof #IBPR at #NHRI,onbeingelectedtotheNationalAcademyofInventors(#NAI).✨Theirrecognitionofesteemed #innovators likeDr.Hsiehistrulyanhonor...
GBI International
GBI Highlights

MEDGAEA LIFE SCIENCES has strategically partnered with Japan's largest preclinical CRO, SNBL

2023-12-31/GlobalBio & Investment
Asthesayinggoes,ifyouwanttogofar,gotogether.Choosingtherightpartnershipiscrucialinbusinessdevelopment.MEDGAEALIFESCIENCEShasstrategicallypartneredwithJapan'slargestpreclinicalCRO, SNBL toestablish...
GBI International
GBIHighlights

BioPreventiveMedicine’s DNlite-IVD103 has approved by SFDA

2023-12-31/GlobalBio & Investment
“Anounceofpreventionisworthapoundofcure”.Let’sgivearoundofapplauseto #BioPreventiveMedicine’sDNlite-IVD103!Thisstate-of-the-arttestiscapableofpredicting #kidney functiondecline...
GBI International
GBI Highlights

BRIM Biotech facilitated the enrollment for a Phase III clinical trial of their dry eye disease drug

2023-12-31/GlobalBio & Investment
Diveinto BRIMBiotechnology,Inc. 'stranslationalmedicinestrategythatfacilitatedtheenrollmentforaPhaseIIIclinicaltrialoftheirdryeyediseasedrugwithinONEyear!✨Discovermorein-depthcoveragehere:https://...
GBI International
GBIHighlights

Vita Genomics partners with Volition to introduce early screening for cancer in pets

2023-12-31/GlobalBio & Investment
Evenourfurryfriendsdeserveprecisemedicalcareandhumanetreatment!VitaGenomicspartnerswith Volition tointroduceearlyscreeningforcancerinpets.Readmoreaboutthisinitiativeandelevatethequalityoflifeforpetsan...
GBI International
GBIHighlights HealthcareExpo

Strategies for Medtech Startups to succeed in the US market

2023-12-31/GlobalBio & Investment
Strategiesfor #medtech #startups tosucceedintheUSmarket?Utilizelocalnetworksandaccessregionalmedicaldata.ExplorefurtherinsightsinGlobalbio'srecapofthe2023MedtechStarthubeventat Healthcare+ExpoTaiw...
GBI International
GBIHighlights

NBRP’s mRNA facility accelerates progress in mRNA-related clinical trials

2023-12-31/GlobalBio & Investment
Thetherapeuticuseof #mRNA hasfueledgreathopetofightabroadrangeofincurablediseases.NotjustagainstCOVID-19butalso craftingpersonalizedcancervaccines!ExcitingnewsawaitsaswehopeforNBRP’smRNAfaciliti...
GBI International
GBIHighlights

Introducing the CellTech Innovation Accelerator, where innovation begins from "zero to one"

2023-12-31/GlobalBio & Investment
Introducingthe CellTechInnovation Accelerator,whereinnovationbeginsfrom"zerotoone"-creatingtheextraordinary.AsAsia'spremierCellandGeneTherapy(CGT)accelerator,itsmissionistobringtogetherd...
GBI International
GBIHighlights

Explore the realms of biomedical and life sciences in our 111th issue

2023-12-31/GlobalBio & Investment
Exploretherealmsof #biomedical andlifesciences?Inour111thissue, #Globalbio'sreportersdivedintothedynamic LifeSciencesBaltics in #Lithuania,wherethenationhasputitswholeweightbehindfosteringthegrowt...
GBI International
GBIHighlights celltherapy

3 industry frontrunners are leading the race of cell therapy to Phase III clinical trials

2023-12-31/GlobalBio & Investment
It'sgreattoseethat UNICOCELL hasdecidedtopursueastocklistingontheTaiwanInnovationBoard.Theyjoinnineotherdomesticcompanieswhohavealsotakenthisstepin2023. Taiwan'scelltherapyclinicaltrialsareint...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務